Chatbot Implementation In The Clinical Informed Consent Process
ConditionInformed Consent
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.
Eligibility criteria
Qualifiers
Ability to understand and willingness to provide informed consent.
Age ≥18 years.
Patients whose preferred language is English.
Patients who are being considered for enrollment in selected clinical research studies.
Disqualifiers
None
Trial design
Treatments tested in this trial
- CoCo Chatbot
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov